Raul R Rodriguez is CEO, President of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 2.04 Million shares of RIGL, which is worth approximately $27.1 Million. The most recent transaction as insider was on Feb 05, 2024, when has been sold 30,545 shares (Common Stock) at a price of $1.14 per share, resulting in proceeds of $34,821. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.04M
0% 3M change
21.18% 12M change
Total Value Held $27.1 Million

RAUL R RODRIGUEZ Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2024
SELL
Open market or private sale
$34,821 $1.14 p/Share
30,545 Reduced 1.48%
2,036,629 Common Stock
Feb 02 2024
SELL
Open market or private sale
$25,254 $1.13 p/Share
22,349 Reduced 1.07%
2,067,174 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
400,000 Added 16.07%
2,089,523 Common Stock
Feb 06 2023
SELL
Open market or private sale
$35,595 $1.75 p/Share
20,340 Reduced 1.2%
1,680,713 Common Stock
Jan 26 2023
BUY
Grant, award, or other acquisition
-
300,000 Added 14.99%
1,701,053 Common Stock
Jun 09 2022
BUY
Open market or private purchase
$690,000 $0.69 p/Share
1,000,000 Added 41.81%
1,391,776 Common Stock
Jan 24 2022
BUY
Grant, award, or other acquisition
-
200,000 Added 33.8%
391,776 Common Stock
RRR

Raul R Rodriguez

CEO, President
South San Francisco, CA

Track Institutional and Insider Activities on RIGL

Follow RIGEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RIGL shares.

Notify only if

Insider Trading

Get notified when an Rigel Pharmaceuticals Inc insider buys or sells RIGL shares.

Notify only if

News

Receive news related to RIGEL PHARMACEUTICALS INC

Track Activities on RIGL